1,2,4-Triazin-3-amine, 6-(2-chloro-6-methyl-4-pyridinyl)-5-(4-fluorophenyl)-, 1g

Potassium peroxomonosulphate triple salt, pure, 500 g, plastic packaging.

4-Chloro-2-methyl-1H-indole, 95.0%, 250mg

4-(Hydroxymethyl)-1-methylpiperidin-2-one, 95.0%, 500mg

1-(4-CHLORO-3-FLUOROPYRIDIN-2-YL)ETHANONE, 95%, 250mg

N-BOC-6-hydroxy-1,4-oxazepane, 97.0%, 1g

4-Hydroxyphenyl Methacrylate (stabilized with HQ)>98.0%(GC)1g

3-(2,5-Dioxo-4-phenylimidazolidin-4-yl)propanoic acid, 95.0%, 100mg

ethyl 8-[4-(4-methylpiperazinomethyl)phenyl]-8-oxooctanoate, 97.0%, 1g

2,5-Dioxopyrrolidin-1-yl 2,2-dimethyl-4-oxo-3,8,11-trioxa-5-azatetradecan-14-oate, 95%, 250mg

L-tert-Leucine, 98.0%, 25g

2-Methyl-1H-pyrrole-3-carboxylic acid, 95.0%, 1g

Dialysis membrane Spectra/Por® Biotech CE MWCO 100–500, 10 mm, 1 Piece(s)